I disagree. Our CEO and Chairperson both joined post the...

I disagree. Our CEO and Chairperson both joined post the original blow up and for the most part have done a good job in difficult circumstances. And we have new directors in Chris Behrenbruch, Robert Ryan and John Michailidis. Importantly all three directors are not part of the "jobs for the boys" network of Aussie biotech directors that has made Australian biotech such an embarrassment. Instead all three have proper international experience with world class companies. I personally believe this is as close to an A grade team that you can get at the tiddler end of the market. Hopefully at some point the market agrees and rerates FTT to a market cap that reflects my confidence!